Início › Linfoma › Distrito de Columbia › Washington
Ensaios clínicos de Linfoma em Washington, DC
23 estudos para Linfoma estão buscando participantes em locais em Washington e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
RecrutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
RecrutandoFase 1/2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
RecrutandoFase 1/2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
RecrutandoFase 2
- Maryland Oncology Hematology, Silver Spring · a 7 mi de distância
Collection of Tissue Samples for Cancer Research
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
RecrutandoFase 1/2
- Children's National Medical Center, Washington D.C.
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
RecrutandoFase 3
- Research Site, Bethesda · a 7 mi de distância
Sample Collection and Tracking for the Developmental Therapeutics Clinic
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
RecrutandoEstudo observacional
- Walter Reed National Military Medical Center, Bethesda · a 7 mi de distância
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
RecrutandoFase 3
- Georgetown University, Washington D.C.
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecrutandoFase 1/2
- Medstar Georgetown University Hospital, Washington D.C.
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
RecrutandoFase 2
- Georgetown University (Data Collection Only), Washington D.C.
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RecrutandoFase 3
- MedStar Georgetown University Hospital, Washington D.C.
Vaccine Responses in Patients With B Cell Malignancies
RecrutandoFase 4
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Mosaic Trial for Stem Cell Transplant Recipients
Recrutando
- Georgetown University School of Medicine, Washington D.C.
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RecrutandoFase 1
- National Institute of Health, Bethesda · a 7 mi de distância
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
RecrutandoEstudo observacional
- George Washington University, Washington D.C.
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
RecrutandoFase 1
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Ensaios de Linfoma em outras cidades
- Houston, TX34 estudos
- Boston, MA33 estudos
- New York City, NY33 estudos
- Baldwin Park, CA21 estudos
- Chicago, IL20 estudos
- Durham, NC17 estudos
- St. Louis, MO15 estudos
- Philadelphia, PA15 estudos
- Cleveland, OH14 estudos
- Edison, NJ12 estudos
- Atlanta, GA12 estudos
- Seattle, WA12 estudos
Outros estudos em Washington
- Câncer (todos os tipos)58 estudos
- Câncer de Pulmão de Não Pequenas Células55 estudos
- Câncer de Mama46 estudos
- Câncer Metastático43 estudos
- Câncer de Pulmão41 estudos
- Câncer de Próstata38 estudos
- Obesidade33 estudos
- Câncer Colorretal29 estudos
- Doença Cardiovascular28 estudos
- Câncer de Bexiga26 estudos
- Leucemia Mieloide Aguda24 estudos
- Câncer de Ovário23 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.